Tuberculosis

	Eight TB CSHGP grants were awarded over the past five years to seven NGOs/PVOs. Their successes, constraints, failures, and impact were evaluated, along with lessons learned. Read the new TB Child Survival and Health Grants Program Evaluation [PDF, 882KB]. Source: Edward Reilly, Lutheran World Relief

Overview

The U.S. Agency for International Development (USAID), in close collaboration with global, regional, and developing country partners, is committed to addressing the global burden of tuberculosis (TB), which kills about 1.7 million people annually. Over the past six years the United States has helped provide effective treatment for 10 million people with TB in 78 countries. The U.S. Government, through USAID, is the leading bilateral donor in the world for TB and supports the expansion and strengthening of TB control in 37 countries. Between 2000 and 2006, USAID provided about $500 million to support TB programs worldwide.

USAID's goal is to make a significant contribution to global, regional, and national efforts to prevent and control tuberculosis and reduce morbidity and mortality associated with the disease. The Agency’s support strengthens the ability of countries most affected by TB to expand the use of proven and cost-effective interventions – such as the internationally recognized Directly-Observed Therapy, Short Course (DOTS) strategy – and achieve the World Health Organization (WHO) targets for TB case detection and cure rates. USAID is also addressing theemerging threat of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB by stepping up support to strengthen laboratories to improve case detection, infection control, surveillance, and training of health care providers in the diagnosis and treatment of MDR and XDR TB, all key components of the Global Response Plan.

USAID Programs Use the Following Approaches:

• Direct Observed Treatment, Short-Course (DOTS) Expansion
• TB Partnerships
• Training
• Research
• Monitoring and Evaluation
• TB/HIV Co-Infection
• Multidrug-Resistant TB (MDR TB)
• Extensively Drug-Resistant TB (XDR TB)
• Pharmaceutical Management

USAID's Strategy for Combating Tuberculosis

1. Expand and strengthen DOTS
2. Increase and strengthen human resource capacity
3. Develop and disseminate new tools and approaches
4. Adapt DOTS to address special challenges

Success Stories

• USAID's Key Achievements and Success Stories